Idex Corp (IEX) financial statements: income statement, balance sheet and cash flow

Idex Corp's income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), Idex Corp reported revenue of $3.5B (+5.8% year on year) and net income of $483.2M (-4.3% year on year).

Income statement

Idex Corp income statement, fiscal years
Line itemDec 31, 2025 · FYDec 31, 2024 · FYDec 31, 2023 · FYDec 31, 2022 · FY
Net sales$3.5B$3.3B$3.3B$3.2B
Cost of sales$1.9B$1.8B$1.8B$1.8B
Gross profit$1.5B$1.4B$1.4B$1.4B
Selling, general and administrative expenses$818.8M$758.7M$703.5M$652.7M
Restructuring expenses and asset impairments$20.7M$9.3M$10.9M$22.8M
Operating income$699.3M$677.2M$732.5M$751.4M
Gain on sale of businesses – net$0($4.0M)($84.7M)($34.8M)
Other expense (income) – net$2.3M($2.6M)$5.2M($3.9M)
Interest expense - net$64.4M$44.5M——
Income before income taxes$632.6M$639.3M$760.3M$749.4M
Provision for income taxes$150.1M$134.7M$164.7M$162.7M
Net income$482.5M$504.6M$595.6M$586.7M
Net loss attributable to noncontrolling interest$700.0K$400.0K$500.0K$200.0K
Net income attributable to IDEX$483.2M$505.0M$596.1M$586.9M
Basic earnings per common share attributable to IDEX (in dollar per share)$6.41$6.66$7.87$7.74
Diluted earnings per common share attributable to IDEX (in dollar per share)$6.41$6.64$7.85$7.71
Basic weighted average common shares outstanding (in shares)75.3M75.7M75.6M75.7M
Diluted weighted average common shares outstanding (in shares)75.3M75.9M75.9M76.0M
Idex Corp income statement, quarters
Line itemJun 30, 2026 · Q2Mar 31, 2026 · Q1Sep 30, 2025 · Q3Jun 30, 2025 · Q2
Net sales$920.6M$886.9M$878.7M$865.4M
Cost of sales$493.8M$488.8M$488.1M$473.2M
Gross profit$426.8M$398.1M$390.6M$392.2M
Selling, general and administrative expenses$224.1M$218.3M$204.7M$203.6M
Restructuring expenses and asset impairments$2.8M$7.4M$100.0K$700.0K
Operating income$199.9M$172.4M$185.8M$187.9M
Other (income) expense – net($1.3M)($600.0K)($1.2M)$2.4M
Interest expense – net$15.1M$16.0M$16.5M$15.6M
Income before income taxes$186.1M$157.0M$170.5M$169.9M
Provision for income taxes$42.7M$37.1M$42.8M$38.8M
Net income$143.4M$119.9M$127.7M$131.1M
Net loss attributable to noncontrolling interest$0$100.0K$100.0K$500.0K
Net income attributable to IDEX$143.4M$120.0M$127.8M$131.6M
Basic earnings per common share attributable to IDEX (in dollars per share)$1.94$1.61$1.70$1.74
Diluted earnings per common share attributable to IDEX (in dollars per share)$1.93$1.61$1.70$1.74
Basic weighted average common shares outstanding (in shares)74.0M74.3M75.1M75.5M
Diluted weighted average common shares outstanding (in shares)74.2M74.4M75.2M75.5M

Balance sheet

Idex Corp balance sheet, fiscal years
Line itemDec 31, 2025 · FYDec 31, 2024 · FYDec 31, 2023 · FYDec 31, 2022 · FY
Cash and cash equivalents$580.0M$620.8M$534.3M$430.2M
Receivables – net$521.7M$465.9M$427.8M$442.8M
Inventories – net$479.4M$429.7M$420.8M$470.9M
Other current assets$62.1M$76.3M$63.4M$55.4M
Total current assets$1.6B$1.6B$1.4B$1.4B
Property, plant and equipment – net$468.0M$460.4M$430.3M$382.1M
Goodwill$3.4B$3.3B$2.8B$2.6B
Intangible assets – net$1.2B$1.3B$1.0B$947.8M
Other noncurrent assets$153.9M$155.7M$138.5M$144.6M
Total assets$6.9B$6.7B$5.9B$5.5B
Trade accounts payable$224.7M$197.8M$179.7M$208.9M
Accrued expenses$297.0M$278.7M$271.5M$289.1M
Current portion of long-term borrowings$700.0K$100.7M$600.0K—
Dividends payable$53.0M$52.5M$48.5M$45.6M
Total current liabilities$575.4M$629.7M$500.3M$543.6M
Long-term borrowings – net$1.8B$1.9B$1.3B$1.5B
Deferred income taxes$303.0M$267.2M$291.9M$264.2M
Other noncurrent liabilities$202.3M$194.8M$206.7M$195.8M
Total liabilities$2.9B$3.0B$2.3B$2.5B
Authorized: 5.0 million shares, $0.01 per share par value; Issued: None$0.00$0.00$0.00$0.00
Authorized: 150.0 million shares, $0.01 per share par value Issued: 90.1 million shares at both December 31, 2025 and 2024$900000.00$900000.00$900000.00$900000.00
Treasury stock at cost: 15.5 million shares at December 31, 2025 and 14.2 million shares at December 31, 2024-1.4B-1.2B-1.2B—
Additional paid-in capital$892.1M$864.8M$839.0M$817.2M
Retained earnings$4.5B$4.2B$3.9B$3.5B
Accumulated other comprehensive income (loss)$57.6M($130.9M)($45.8M)($126.2M)
Total shareholders’ equity$4.0B$3.8B$3.5B$3.0B
Noncontrolling interest($1.3M)($600.0K)($200.0K)$300.0K
Total equity$4.0B$3.8B$3.5B$3.0B
Total liabilities and equity$6.9B$6.7B$5.9B$5.5B
Idex Corp balance sheet, quarters
Line itemJun 30, 2026Mar 31, 2026Sep 30, 2025Jun 30, 2025
Cash and cash equivalents$621.3M$586.2M$593.8M$568.2M
Receivables – net$547.8M$553.0M$500.2M$476.1M
Inventories – net$520.3M$501.0M$495.1M$487.8M
Other current assets$83.9M$76.5M$65.8M$84.4M
Total current assets$1.8B$1.7B$1.7B$1.6B
Property, plant and equipment – net of accumulated depreciation of $686.4 and $654.3 at June 30, 2026 and December 31, 2025, respectively$463.6M$462.3M$468.6M$464.8M
Goodwill$3.4B$3.4B$3.4B$3.4B
Intangible assets – net$1.2B$1.2B$1.3B$1.3B
Other noncurrent assets$146.0M$149.2M$155.9M$156.8M
Total assets$6.9B$6.9B$7.0B$6.9B
Trade accounts payable$233.7M$224.8M$208.1M$204.2M
Accrued expenses$293.5M$280.6M$302.0M$271.3M
Current portion of long-term borrowings$400.0K$500.0K$700.0K$800.0K
Dividends payable$54.0M$100.0K$53.2M$53.5M
Total current liabilities$581.6M$506.0M$564.0M$529.8M
Long-term borrowings – net$1.9B$1.9B$1.9B$1.8B
Deferred income taxes$297.8M$299.5M$287.8M$283.2M
Other noncurrent liabilities$185.5M$192.9M$206.2M$205.6M
Total liabilities$2.9B$2.9B$3.0B$2.9B
Authorized: 5.0 million shares, $0.01 per share par value; Issued: None$0.00$0.00$0.00$0.00
Authorized: 150.0 million shares, $.01 per share par value Issued: 90.1 million shares at both June 30, 2026 and December 31, 2025$900000.00$900000.00$900000.00$900000.00
Treasury stock at cost: 16.1 million shares at June 30, 2026 and 15.5 million shares at December 31, 2025-1.5B-1.5B-1.3B-1.3B
Additional paid-in capital$875.2M$868.5M$888.5M$883.6M
Retained earnings$4.7B$4.6B$4.4B$4.4B
Accumulated other comprehensive income$1.6M$13.9M$45.3M$48.2M
Total shareholders’ equity$4.0B$4.0B$4.0B$4.0B
Noncontrolling interest($1.4M)($1.4M)($1.3M)($1.2M)
Total equity$4.0B$4.0B$4.0B$4.0B
Total liabilities and equity$6.9B$6.9B$7.0B$6.9B

Cash flow statement

Idex Corp cash flow statement, fiscal years
Line itemDec 31, 2025 · FYDec 31, 2024 · FYDec 31, 2023 · FYDec 31, 2022 · FY
Net income$482.5M$504.6M$595.6M$586.7M
Gain on sale of businesses – net$0($4.0M)($84.7M)($34.8M)
Asset Impairments$700.0K$100.0K$800.0K$17.4M
Credit loss on note receivable from collaborative partner$0$0$7.7M—
Depreciation$75.8M$68.5M$57.2M$50.7M
Amortization of intangible assets$130.7M$107.1M$94.9M$69.0M
Share-based compensation expense$27.3M$25.8M$21.8M$21.6M
Deferred income taxes$12.8M($19.4M)($14.7M)($18.5M)
Receivables – net($41.2M)($16.9M)$20.5M($71.7M)
Inventories – net($34.2M)$17.6M$66.2M($72.4M)
Other current assets$1.6M($100.0K)($6.5M)($500.0K)
Trade accounts payable$15.2M$8.9M($25.3M)$17.6M
Deferred revenue$2.7M($17.9M)$12.7M($25.0M)
Accrued expenses$1.8M($8.6M)($34.8M)$16.6M
Other – net$4.7M$2.4M$5.3M$2.5M
Net cash flows provided by operating activities$680.4M$668.1M$716.7M$557.4M
Capital expenditures($63.6M)($65.1M)($89.9M)($68.0M)
Acquisition of businesses, net of cash acquired($76.2M)($984.5M)($311.8M)($945.6M)
Proceeds from sale of businesses, net of cash remitted$0$45.1M$118.6M$49.4M
Purchase of marketable securities$0$0($29.0M)$0
Proceeds from sale of marketable securities$0$4.5M$24.8M$39.7M
Other – net$2.2M($6.5M)$3.5M$1.4M
Net cash flows used in investing activities($137.6M)($1.0B)($283.8M)($917.2M)
Borrowings under revolving credit facilities$252.0M$279.3M$0$210.4M
Payments under revolving credit facilities($322.9M)($69.1M)$0($135.0M)
Proceeds from issuance of long-term borrowings$0$496.7M$100.0M$200.0M
Payment of long-term borrowings($100.0M)($50.0M)($250.0M)$0
Cash dividends paid to shareholders($212.6M)($205.3M)($190.7M)($177.4M)
(Payments) proceeds from share issuances, net of shares withheld for taxes-500.0K———
Repurchases of common stock($247.8M)$0($24.2M)($148.1M)
Other – net($800.0K)($700.0K)($1.3M)—
Net cash flows (used in) provided by financing activities($632.6M)$465.9M($344.7M)($37.8M)
Effect of exchange rate changes on cash and cash equivalents$36.8M($22.9M)$15.9M($27.6M)
Net (decrease) increase in cash and cash equivalents and restricted cash($53.0M)$104.6M$104.1M($425.2M)
Cash and cash equivalents and restricted cash at beginning of year$638.9M$534.3M$430.2M$855.4M
Cash and cash equivalents and restricted cash at end of year$585.9M$638.9M——
Interest$72.2M$47.4M$50.8M$37.1M
Income taxes - net$134.6M$171.4M$199.5M$175.6M
Idex Corp cash flow statement, quarters
Line itemJun 30, 2026 · YTDMar 31, 2026 · Q1Sep 30, 2025 · YTDJun 30, 2025 · YTD
Net income$263.3M$119.9M$354.2M$226.5M
Asset impairments$4.8M$4.8M$700.0K$600.0K
Depreciation$40.1M$19.9M$56.5M$37.4M
Amortization of intangible assets$67.0M$33.8M$96.5M$63.5M
Share-based compensation expense$21.9M$15.8M$23.7M$18.8M
Deferred income taxes($1.3M)($600.0K)($1.0M)$1.6M
Receivables – net($30.7M)($35.4M)($20.2M)$1.6M
Inventories – net($45.7M)($25.5M)($49.4M)($45.6M)
Other current assets($21.4M)($15.1M)($1.4M)($21.8M)
Trade accounts payable$9.2M$600.0K($1.1M)($700.0K)
Deferred revenue$2.7M$4.2M($1.1M)$6.4M
Accrued expenses($8.0M)($18.8M)$10.4M($22.4M)
Other – net$1.8M$100.0K$3.1M$1.5M
Net cash flows provided by operating activities$303.7M$103.7M$470.9M$267.4M
Capital expenditures($40.7M)($17.7M)($43.9M)($29.1M)
Acquisition of business, net of cash acquired$0$0($76.5M)$4.2M
Other – net($2.0M)($2.7M)$400.0K$400.0K
Net cash flows used in investing activities($42.7M)($20.4M)($120.0M)($24.5M)
Borrowings under revolving credit facilities$205.0M$100.0M$197.0M$50.0M
Payments under revolving credit facilities($163.3M)($45.3M)($185.8M)($92.7M)
Payment of long-term borrowings$0—($100.0M)($100.0M)
Cash dividends paid to shareholders($106.7M)($52.8M)($159.4M)($105.9M)
Proceeds (payments) from share issuances, net of shares withheld for taxes10.6M5.8M-1.2M-200.0K
Repurchases of common stock($153.4M)($76.3M)($175.0M)($100.0M)
Other – net($300.0K)($200.0K)($500.0K)($400.0K)
Net cash flows used in financing activities($208.1M)($68.8M)($424.9M)($349.2M)
Effect of exchange rate changes on cash and cash equivalents($10.7M)($8.6M)$34.8M$37.4M
Net increase (decrease) in cash and cash equivalents and restricted cash$42.2M$5.9M($39.2M)($68.9M)
Cash and cash equivalents and restricted cash at beginning of year$585.9M$585.9M$638.9M$638.9M
Cash and cash equivalents and restricted cash at end of period$628.1M$591.8M$599.7M$570.0M
Interest$34.4M$15.1M$52.1M$36.7M
Income taxes – net$81.4M$19.7M$103.3M$83.4M

Idex Corp score and earnings-call analysis · All covered companies

Figures as reported in SEC filings. General information, not investment advice.